UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 1.888

Sortiert nach

Mucosal immunization with a low-energy electron inactivated respiratory syncytial virus vaccine protects mice without Th2 immune bias

Frontiers in immunology, 2024, Vol.15, p.1382318-1382318

2024

Link zum Volltext

Verfügbarkeit prüfen

Prefusion F Protein–Based Respiratory Syncytial Virus Immunization in Pregnancy

The New England journal of medicine, 2022-04, Vol.386 (17), p.1615-1626

2022

Link zum Volltext

Verfügbarkeit prüfen

The race to make vaccines for a dangerous respiratory virus

Nature (London), 2021-12, Vol.600 (7889), p.379-380

Powell, Kendall

2021

Link zum Volltext

Verfügbarkeit prüfen

Viral N 6 -methyladenosine upregulates replication and pathogenesis of human respiratory syncytial virus

Nature communications, 2019-10, Vol.10 (1), p.4595-18

2019

Link zum Volltext

Verfügbarkeit prüfen

An Adjuvanted, Postfusion F Protein–Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults

The Journal of infectious diseases, 2017-12, Vol.216 (11), p.1362-1370

2017

Link zum Volltext

Verfügbarkeit prüfen

Investigational RSV Vaccine Given During Pregnancy Protects Newborns

JAMA : the journal of the American Medical Association, 2022-12, Vol.328 (22), p.2201

Larkin, Howard

2022

Link zum Volltext

Verfügbarkeit prüfen

Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection

Antimicrobial agents and chemotherapy, 2016-01, Vol.60 (1), p.6-13

2016

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model

Nature communications, 2018-05, Vol.9 (1), p.1904-10, Article 1904

2018

Link zum Volltext

Verfügbarkeit prüfen

Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality?

The Lancet infectious diseases, 2016-08, Vol.16 (8), p.e153-e163

2016

Link zum Volltext

Verfügbarkeit prüfen

Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older Adults

Clinical infectious diseases, 2024-05, Vol.78 (5), p.1360-1368

2024

Link zum Volltext

Verfügbarkeit prüfen

A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant

The Journal of infectious diseases, 2017-01, Vol.215 (1), p.24-33

2017

Link zum Volltext

Verfügbarkeit prüfen

Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective

Journal of virology, 2017-05, Vol.91 (10)

2017

Link zum Volltext

Verfügbarkeit prüfen

Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children

The Journal of infectious diseases, 2020-02, Vol.221 (4), p.534-543

2020

Link zum Volltext

Verfügbarkeit prüfen

Passive and active immunization against respiratory syncytial virus for the young and old

Expert review of vaccines, 2017-07, Vol.16 (7), p.737-749

2017

Link zum Volltext

Verfügbarkeit prüfen

The CD4 T cell response to respiratory syncytial virus infection

Immunologic research, 2014-08, Vol.59 (1-3), p.109-117

2014

Link zum Volltext

Verfügbarkeit prüfen

Exacerbated lung inflammation in offspring with high maternal antibody levels following secondary RSV exposure

Frontiers in immunology, 2024-04, Vol.15, p.1377374-1377374

2024

Link zum Volltext

Verfügbarkeit prüfen

RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection

Nature communications, 2015-12, Vol.6 (1), p.10224-10224, Article 10224

2015

Link zum Volltext

Verfügbarkeit prüfen

A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models

PloS one, 2015-03, Vol.10 (3), p.e0119509-e0119509

2015

Link zum Volltext

Verfügbarkeit prüfen

Partial Attenuation of Respiratory Syncytial Virus with a Deletion of a Small Hydrophobic Gene Is Associated with Elevated Interleukin-1β Responses

Journal of virology, 2015-09, Vol.89 (17), p.8974-8981

2015

Link zum Volltext

Verfügbarkeit prüfen

Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age

PloS one, 2013-10, Vol.8 (10), p.e77104

2013

Link zum Volltext

Verfügbarkeit prüfen

Lung ILC2s are activated in BALB/c mice born to immunized mothers despite complete protection against respiratory syncytial virus

Frontiers in immunology, 2024-05, Vol.15, p.1374818-1374818

2024

Link zum Volltext

Verfügbarkeit prüfen

Safety and Immunogenicity of 3 Formulations of an Investigational Respiratory Syncytial Virus Vaccine in Nonpregnant Women: Results From 2 Phase 2 Trials

The Journal of infectious diseases, 2018-04, Vol.217 (10), p.1616-1625

2018

Link zum Volltext

Verfügbarkeit prüfen

Clinical and epidemiologic features of respiratory syncytial virus

Current topics in microbiology and immunology, 2013, Vol.372, p.39

2013

Link zum Volltext

Verfügbarkeit prüfen

Dose Selection for an Adjuvanted Respiratory Syncytial Virus F Protein Vaccine for Older Adults Based on Humoral and Cellular Immune Responses

Clinical and vaccine immunology, 2017-09, Vol.24 (9)

2017

Link zum Volltext

Verfügbarkeit prüfen

Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection

PLoS medicine, 2013-11, Vol.10 (11), p.e1001549-e1001549

2013

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.888

Suche als RSS-Feed

Aktive Filter

KollektionElsevier Journal Backfiles on ScienceDirect (DFG Nationallizenzen)

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.788)
Mit Volltextzugriff
(1.604)

Publikationsform

Sprache

10 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.697)
Life Sciences & Biomedicine
(1.586)
Humans
(1.496)
Male
(1.240)
Respiratory Syncytial Virus
(1.165)
Immunology
(1.004)
Infant
(860)
Infectious Diseases
(822)
Animals
(651)
Respiratory Syncytial Virus Infections - Immunology
(630)
Biological And Medical Sciences
(609)
Child, Preschool
(527)
Medical Sciences
(518)
Respiratory Syncytial Viruses - Immunology
(516)
Microbiology
(487)
Mice
(454)
Pediatrics
(448)
Infant, Newborn
(443)
Viruses
(405)

14 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(13)

Menü

Weitere Dienste

Einstellungen

Mucosal immunization with a low-energy electron inactivated respiratory syncytial virus vaccine protects mice without Th2 immune bias

Prefusion F Protein–Based Respiratory Syncytial Virus Immunization in Pregnancy

The race to make vaccines for a dangerous respiratory virus

Viral N 6 -methyladenosine upregulates replication and pathogenesis of human respiratory syncytial virus

An Adjuvanted, Postfusion F Protein–Based Vaccine Did Not Prevent Respiratory Syncytial Virus Illness in Older Adults

Investigational RSV Vaccine Given During Pregnancy Protects Newborns

Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection

Efficacy of a respiratory syncytial virus vaccine candidate in a maternal immunization model

Vaccination against respiratory syncytial virus in pregnancy: a suitable tool to combat global infant morbidity and mortality?

Safety and Immunogenicity of Bivalent RSVpreF Vaccine Coadministered With Seasonal Inactivated Influenza Vaccine in Older Adults

A Randomized, Controlled, Observer-Blinded Phase 1 Study of the Safety and Immunogenicity of a Respiratory Syncytial Virus Vaccine With or Without Alum Adjuvant

Mutating the CX3C Motif in the G Protein Should Make a Live Respiratory Syncytial Virus Vaccine Safer and More Effective

Live Respiratory Syncytial Virus Attenuated by M2-2 Deletion and Stabilized Temperature Sensitivity Mutation 1030s Is a Promising Vaccine Candidate in Children

Passive and active immunization against respiratory syncytial virus for the young and old

The CD4 T cell response to respiratory syncytial virus infection

Exacerbated lung inflammation in offspring with high maternal antibody levels following secondary RSV exposure

RSV-specific airway resident memory CD8+ T cells and differential disease severity after experimental human infection

A novel respiratory syncytial virus (RSV) F subunit vaccine adjuvanted with GLA-SE elicits robust protective TH1-type humoral and cellular immunity in rodent models

Partial Attenuation of Respiratory Syncytial Virus with a Deletion of a Small Hydrophobic Gene Is Associated with Elevated Interleukin-1β Responses

Safety and immunogenicity of a live attenuated RSV vaccine in healthy RSV-seronegative children 5 to 24 months of age

Lung ILC2s are activated in BALB/c mice born to immunized mothers despite complete protection against respiratory syncytial virus

Safety and Immunogenicity of 3 Formulations of an Investigational Respiratory Syncytial Virus Vaccine in Nonpregnant Women: Results From 2 Phase 2 Trials

Clinical and epidemiologic features of respiratory syncytial virus

Dose Selection for an Adjuvanted Respiratory Syncytial Virus F Protein Vaccine for Older Adults Based on Humoral and Cellular Immune Responses

Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection

Aktive Filter

Suchergebnisse filtern